Carregant...
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive neuromuscular disease prevalent in 1 in 3500 to 5000 males worldwide. As a result of mutations that interrupt the reading frame of the dystrophin gene (DMD), DMD is characterized by a loss of dystrophin protein that leads to decreased m...
Guardat en:
| Publicat a: | J Pers Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313657/ https://ncbi.nlm.nih.gov/pubmed/30477208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm8040038 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|